HLS Therapeutics Q2 2019 Investor Presentation

HLS Therapeutics is a Canadian-based, North American-focused pharmaceutical company presenting its post-Q2 2019 strategy. The presentation outlines the company's staged approach emphasizing foundational cash flow, transformative organic growth, and late-stage clinical programs supported by operational pharma expertise and a strong balance sheet.